enVVeno Medical Corporation
NVNO
$0.39
-$0.01-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.40M | 12.13M | 11.52M | 11.58M | 11.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.95M | 23.95M | 23.28M | 23.83M | 23.41M |
| Operating Income | -22.95M | -23.95M | -23.28M | -23.83M | -23.41M |
| Income Before Tax | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.97 | -23.07 | -21.33 | -21.82 | -21.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M |
| EBIT | -22.95M | -23.95M | -23.28M | -23.83M | -23.41M |
| EBITDA | -22.81M | -23.79M | -23.10M | -23.64M | -23.20M |
| EPS Basic | -1.08 | -1.21 | -1.19 | -1.28 | -1.33 |
| Normalized Basic EPS | -0.68 | -0.76 | -0.79 | -0.86 | -0.91 |
| EPS Diluted | -1.08 | -1.21 | -1.19 | -1.28 | -1.33 |
| Normalized Diluted EPS | -0.68 | -0.76 | -0.79 | -0.86 | -0.91 |
| Average Basic Shares Outstanding | 81.24M | 77.15M | 72.87M | 68.57M | 63.70M |
| Average Diluted Shares Outstanding | 81.24M | 77.15M | 72.87M | 68.57M | 63.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |